Showing results (1101-1110 of 4,514) with videos related to
Sort By:
Pageof 452
Future Oncology (London, England)|May 3, 2018
The importance of food, nutrition and physical activity in cancer prevention: an interview with Dr Kate AllenKate AllenFuture Oncology (London, England)|June 21, 2014
EASL HCC summit: liver cancer managementRodolfo Sacco, Gennaro Gadaleta-Caldarola, Giovanni Galati, et al.Future Oncology (London, England)|June 16, 2026
Time-to-progression ratio as a potential study endpoint in early-phase oncology trials: pooled analysis of phase II trials from the Australian MoST programDerrick H W Siu, Frank P Y Lin, David M Thomas, et al.Future Oncology (London, England)|July 30, 2016
ASTRO APEx® and RO-ILS™ are applicable to medical malpractice in radiation oncologyNicholas G Zaorsky, Anthony G Ricco, Thomas M Churilla, et al.Future Oncology (London, England)|July 21, 2023
Time to next treatment in patients with chronic lymphocytic leukemia initiating first-line ibrutinib or acalabrutinibRyan Jacobs, Xiaoxiao Lu, Bruno Emond, et al.Future Oncology (London, England)|July 21, 2023
The burden of ovarian cancer in the USA from 2007 to 2018: evidence from the Medical Expenditure Panel SurveyElizabeth A Szamreta, Wei-Jhih Wang, Ruchit Shah, et al.Future Oncology (London, England)|July 19, 2023
Safety and efficacy of left colic artery preservation in laparoscopic anterior resection for lower rectal cancerZonglin Li, Yejiang Zhou, Linxia Xu, et al.Future Oncology (London, England)|June 27, 2023
Rash with different types of BCR-ABL inhibitors in chronic myelogenous leukemia: a systematic review and meta-analysisSu Li, Tingwen Wang, Yu Zhong, et al.Future Oncology (London, England)|June 30, 2023
TROPION-Breast01: Datopotamab deruxtecan vs chemotherapy in pre-treated inoperable or metastatic HR+/HER2- breast cancerAditya Bardia, Komal Jhaveri, Kevin Kalinsky, et al.Future Oncology (London, England)|June 30, 2023
Clinical outcomes of intensive versus less intensive first-line chemotherapy for metastatic colorectal cancerKentaro Yamazaki, Satoshi Yuki, Eiji Oki, et al.Pageof 452